
Pfizer/BioNTech submit initial data on Covid-19 vaccine for people ages 5 to 11 to FDA, but aren't seeking EUA yet
CNN
Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking emergency use authorization.
A formal submission to request EUA for the vaccine is expected to follow in the coming weeks, the companies said in a statement.
Submissions to the European Medicines Agency and other regulatory authorities are also planned, they said.
More Related News

Oklahoma’s governor picks energy executive Alan Armstrong to fill US Senate seat through end of year
Oklahoma’s governor on Tuesday appointed energy executive Alan Armstrong to serve in the US Senate through the end of the year and finish the term of Republican Markwayne Mullin, the new homeland security secretary.












